Raymond James Financial Services Advisors, Inc. - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 26 filers reported holding EVOKE PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-10.0%
108,5450.0%0.00%
Q4 2021$60,000
-57.4%
108,5450.0%0.00%
Q3 2021$141,000
-13.5%
108,545
-8.9%
0.00%
Q2 2021$163,000119,1900.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 32,000$113,0000.09%
Cetera Advisor Networks LLC 30,260$107,0000.00%
Creative Planning 100,000$354,0000.00%
OPTIMUM INVESTMENT ADVISORS 800$3,0000.00%
Lindbrook Capital, LLC 1,000$4,0000.00%
NORTHERN TRUST CORP 37,438$133,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 188,514$667,0000.00%
CITIGROUP INC 500$2,0000.00%
GOLDMAN SACHS GROUP INC 35,174$125,0000.00%
View complete list of EVOKE PHARMA INC shareholders